Skip to main content
OpenTrials

Clinical trial condition

Homozygous Familial Hypercholesterolemia

Explore clinical trials studying Homozygous Familial Hypercholesterolemia. Study availability and eligibility vary by location and protocol.

57 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Homozygous Familial Hypercholesterolemia trial results

Completed

An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia

NCT00694109

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +14 more
Locations
  • Mission Viejo, California, United States
  • Newport Beach, California, United States
  • Bridgeport, Connecticut, United States
  • Melbourne, Florida, United States
View all 33 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

NCT02226198

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Research Site Brussels (Woluwé-St-Lambert), Belgium
  • Research Site Chicoutimi, Quebec, Canada
  • Research Site København Ø, Denmark
  • Research Site Haifa, Israel
View Trial Details
Completed

Study to Evaluate the Effects of MBX-8025 in Patients With HoFH

NCT02472535

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Ecogene-21 Chicoutimi, Quebec, Canada
  • Montreal Heart Institute Montreal, Quebec, Canada
  • Endocrinologie metabolisme et prevention cardiovasulaire, Institut E3M et IHU cardiometabolique (ICAN), Hôpital Pitié Salpêtrière Paris, France
  • Radbound UMC Nijmegen, Netherlands
View Trial Details
Completed

Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects

NCT01412034

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Clinical Research Facility Hartford, Connecticut, United States
  • Clinical Research Facility North Massapequa, New York, United States
  • Clinical Research Facility Chicoutimi, Quebec, Canada
  • Clinical Research Facility Québec, Quebec, Canada
View Trial Details

Related conditions